Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-1.8x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -180.54% |
| Q3 2025 | 9.56% |
| Q2 2025 | 41.67% |
| Q1 2025 | -11.11% |
| Q4 2024 | 0.00% |
| Q3 2024 | 47.95% |
| Q2 2024 | 19.67% |
| Q1 2024 | -7.58% |
| Q4 2023 | 6.45% |
| Q3 2023 | 8.77% |
| Q2 2023 | 96.55% |
| Q1 2023 | -32.56% |
| Q4 2022 | -4.44% |
| Q3 2022 | 181.25% |
| Q2 2022 | -63.64% |
| Q1 2022 | -8.33% |
| Q4 2021 | -68.63% |
| Q3 2021 | 139.06% |
| Q2 2021 | 220.00% |
| Q1 2021 | -62.96% |
| Q4 2020 | 100.00% |
| Q3 2020 | 42.11% |
| Q2 2020 | 526.97% |
| Q1 2020 | 81.46% |
| Q4 2019 | -41.18% |
| Q3 2019 | -70.00% |
| Q2 2019 | -1100.00% |
| Q1 2019 | 165.36% |
| Q4 2018 | 91.95% |
| Q3 2018 | -18.75% |
| Q2 2018 | 15.79% |
| Q1 2018 | -121.84% |
| Q4 2017 | 4250.00% |
| Q3 2017 | 108.70% |
| Q2 2017 | 11.54% |
| Q1 2017 | -18.18% |
| Q4 2016 | 4.35% |
| Q3 2016 | -9.52% |
| Q2 2016 | -31.25% |
| Q1 2016 | -633.33% |